BIOMERIEUX (P.S.) O.N./ FR0013280286 /
2024-08-30 10:49:33 AM | Chg. -1.10 | Volume | Bid9:59:59 PM | Ask9:59:59 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
105.00EUR | -1.04% | 50 Turnover: 5,260 |
104.70Bid Size: 11 | 105.10Ask Size: 11 | 12.39 bill.EUR | 0.81% | 34.55 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 3.03 EUR | -21.09% |
EPS Diluted: | - EUR | -21.20% |
Revenues per Share: | 31.05 EUR | 2.39% |
Book Value per Share: | 31.70 EUR | 3.00% |
Cash Flow per Share: | 3.76 EUR | -6.25% |
Dividend per Share: | 0.85 EUR | 0.00% |
Total | in mill. | |
Revenues: | 3,674.70 EUR | 2.39% |
Net Income: | 357.60 EUR | -20.95% |
Operating Cash Flow: | 445.40 EUR | - |
Cash and Cash Equivalents: | 352.40 EUR | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 34.55 | 33.20 |
P/S Ratio: | 3.37 | 3.24 |
P/BV ratio: | 3.30 | 3.17 |
P/CF Ratio: | 27.82 | 26.73 |
PEG: | -1.64 | -1.57 |
Earnings Yield: | 2.89% | 3.01% |
Dividend Yield: | 0.81% | 0.84% |
Market Capitalization | ||
Market Capitalization: | 12.39 bill. EUR | 11.91 bill. EUR |
Free Float Market Cap.: | - EUR | - EUR |
Market Cap. / Employee: | - EUR | - EUR |
Shares Outstanding: | 118.36 mill. |
Profitability
Gross Profit Margin: | 55.99% |
EBIT Margin: | 11.95% |
Net Profit Margin: | 9.73% |
Return on Equity: | 9.53% |
Return on Assets: | 6.80% |
Financial Strength
Liquidity I / Cash Ratio: | 32.41% |
Liquidity II / Quick Ratio: | 99.42% |
Liquidity III / Current Ratio: | 202.81% |
Debt / Equity Ratio: | 40.16% |
Dynam. Debt / Equity Ratio: | 338.35% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - EUR |
Revenues / Employee: | - EUR |
Net Income / Employee: | - EUR |
Total Assets / Employee: | - EUR |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | IFRS |
Currency: | EUR |